INTRIGUE: A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib (clinicaltrials.gov) - Oct 17, 2026 - P3 | N=453 | Active, not recruiting | Sponsor: Deciphera Pharmaceuticals, LLC | Trial completion date: Dec 2026 ➔ Dec 2027
Trial completion date • Gastrointestinal Stromal Tumor • Oncology • Sarcoma
|